Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,796.00
(
0.00%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
109.64
(
2.87%
)
Bitcoin
69,869.76
(
-1.93%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 112325

Tuesday, 06/12/2012 5:45:53 PM

Tuesday, June 12, 2012 5:45:53 PM

Post# of 257257
The LLY/B-I diabetes JV issued several PR’s at ADA, which wrapped up today...

Phase-3 Tradjenta data:
http://finance.yahoo.com/news/boehringer-ingelheim-pharmaceuticals-inc-eli-140000500.html

Phase-2 data for LY2605541, a basal insulin compared to Lantus:
http://finance.yahoo.com/news/lilly-boehringer-ingelheim-present-data-203100108.html

Phase-2b extension data for Empagliflozin, a SGLT-2 inhibitor:
http://finance.yahoo.com/news/90-week-data-suggest-sustained-140000190.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now